Yet, further analyses showed that a Myc activation signature in breast tumors [19, 28] was the strongest classifier for these two tumor groups in our study, indicating a major influence of Myc signaling on the proteome in breast cancer. The gene discussed is MYC; the disease is breast carcinoma.